New treatment options for erectile dysfunction.
BACKGROUND
As increasing insight is gained into the aetiology of erectile dysfunction, many men formerly considered as suffering from psychogenic erectile dysfunction are now recognised as suffering from organic disease. As such, these men are currently identified as candidates for aggressive treatment of the organically caused problem.


OBJECTIVE
This article discusses current and recently introduced treatments for erectile dysfunction, highlighting the advantages of each treatment and their position in the therapeutic armamentarium of the general practitioner.


CONCLUSIONS
Investigative and treatment modalities have become more varied, such that to treat sexual dysfunction adequately, physicians must constantly keep abreast of new developments.
McMahon
C G
CG
Australian Centre for Sexual Health, St Luke's Hospital, Sydney, NSW.
D000527:Alprostadil / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D007172:Erectile Dysfunction / Q000175:diagnosis / Q000628:therapy*; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D019935:Penile Implantation / Q000379:methods; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage; D010879:Piperazines / Q000008:administration & dosage*; D011687:Purines; D000068677:Sildenafil Citrate; D013450:Sulfones; D016896:Treatment Outcome; D014665:Vasodilator Agents / Q000008:administration & dosage
D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D000527:Alprostadil